Type 1 diabetes (T1D) impacts nearly two million Americans, and by the time most people learn they have it, most of the body’s insulin-producing cells are destroyed. Now, pinpointing a hidden group of immune “attack” cells in the pancreatic lymph nodes that appear earlier in the disease could offer the first real chance to detect—and even stop—T1D, according to new research from the Perelman School of Medicine at the University of Pennsylvania detailed in Science Immunology.
Type 1 diabetes (T1D) impacts nearly two million Americans, and by the time most people learn they have it, most of the body’s insulin-producing cells are destroyed. Now, pinpointing a hidden group of immune “attack” cells in the pancreatic lymph nodes that appear earlier in the disease could offer the first real chance to detect—and even stop—T1D, according to new research from the Perelman School of Medicine at the University of Pennsylvania detailed in Science Immunology.
